ARTICLE | Company News
CohBar Inc., Alzheimer's Drug Discovery Foundation neurology news
March 11, 2013 7:00 AM UTC
CohBar received $205,260 in funding from ADDF to develop CohBar's Humanin analog, a mitochondrial peptide to treat Alzheimer's disease. ADDF's funding will support a year-long research program, includ...